Recipient of federal assistance · SAN DIEGO, CA

3DT HOLDINGS, LLC

3DT HOLDINGS, LLC received $8.2M in federal grants and other assistance in FY2026, on 11 actions, +669% vs FY2025. It has no federal contracts in the loaded years. Since FY2021: $13.5M. Its largest awarding agency was National Institutes of Health ($8.2M).

Assistance · FY2026
$8.2M
New awards
2
Actions
11
Since FY2021
$13.5M
UEI
E527XPXM1CJ7
Location
SAN DIEGO, CA
Businesses
Open in the explorerFederal grants & assistance

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

Assistance by fiscal year

  1. 186KFY2021
  2. 1.1MFY2022
  3. 835.3KFY2023
  4. 2.1MFY2024
  5. 1.1MFY2025
  6. 8.2MFY2026

By type

  1. Direct payments$7.1M87%
  2. Grants$1.1M13%

Top programs · Awarding agencies

Obligations in FY2026.

Top programs

  1. 93.384 · Advanced Research Projects Agency for Health (Arpa-H)$7.1M87%
  2. 93.837 · Cardiovascular Diseases Research$1.1M13%

Awarding agencies

  1. National Institutes of Health$8.2M100%
    Department of Health and Human Services

Largest awards

  1. AT LAST: ANTI-THROMBOTIC LYMPHATIC STENT THERAPY$4M
    93.384 · Advanced Research Projects Agency for Health (Arpa-H)· National Institutes of Health· Direct payment for specified use· Feb 18, 2026 – Aug 26, 2026· AY2AX000136
  2. DEVICES FOR ASSESSMENT OF THORACIC DUCT STRUCTURE/FUNCTION IN CENTRAL CONDUCTING LYMPHATIC ANOMALY$3.1M
    93.384 · Advanced Research Projects Agency for Health (Arpa-H)· National Institutes of Health· Direct payment for specified use· Nov 7, 2025 – May 20, 2026· AY2AX000114
  3. SOFTWARE-GUIDED OPERATIVE PLANNING OF MITRACLIP PLACEMENT - ABSTRACT MITRAL REGURGITATION (MR) IS THE MOST COMMON TYPE OF VALVULAR HEART…$2.6M
    93.837 · Cardiovascular Diseases Research· National Institutes of Health· Project grant· Sep 20, 2024 – Jun 9, 2026· R44HL169034
  4. LOW PROFILE TRANSCATHETER AORTIC VALVE IMPLANT - ABSTRACT TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) IS GRADUALLY BECOMING AN ESSENTIAL…$497.4K
    93.837 · Cardiovascular Diseases Research· National Institutes of Health· Project grant· Apr 15, 2024 – Aug 4, 2026· R43HL174201
  5. NOVEL STABILIZATION CATHETER FOR HIS PACING LEAD IMPLANT - ABSTRACT HEART FAILURE (HF) IS A NATIONWIDE EPIDEMIC WITH OVER 6 MILLION…$437.5K
    93.837 · Cardiovascular Diseases Research· National Institutes of Health· Project grant· Sep 17, 2024 – Jul 8, 2026· R43HL176260

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 8, 2026, loaded Oct 8, 2026 · FY2021–FY2026.